Background: Whereas accumulating studies on patients with coronavirus disease 2019 (COVID-19) report high incidences of thrombotic complications, large studies on clinically relevant thrombosis in patients with other respiratory tract infections are lacking. How this high risk in COVID-19 patients compares to those observed in hospitalized patients with other viral pneumonias such as influenza is unknown.Objectives: To assess the incidence of venous and arterial thrombotic complications in hospitalized patients with influenza as opposed to that observed in hospitalized patients with COVID-19.Methods: This was a retrospective cohort study; we used data from Statistics Netherlands (study period: 2018) on thrombotic complications in hospitaliz...
Item does not contain fulltextINTRODUCTION: In the first wave, thrombotic complications were common ...
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pr...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature. This article is licensed under a Cre...
Introduction: COVID-19 may predispose to both venous and arterial thromboembolism due to excessive i...
Background:Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pro...
Background. A prothrombotic state, attributable to excessive inflammation, cytokine storm, hypoxia, ...
A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early during th...
Background COVID-19 may predispose to both venous and arterial thromboembolism event (TEE). Report...
Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized COVID-19 pa...
Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized COVID-19 pa...
Introduction: Increasing evidence has declared a hypercoagulable state in the coronavirus 2019 infec...
Background: A possible association between COVID-19 infection and thrombosis, either as a direct con...
Background: There are limited data on the incidence of thrombosis among COVID-19 cases, with most re...
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pr...
Objective: An unexpectedly large number of people infected with Covid-19 had experienced a thrombo...
Item does not contain fulltextINTRODUCTION: In the first wave, thrombotic complications were common ...
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pr...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature. This article is licensed under a Cre...
Introduction: COVID-19 may predispose to both venous and arterial thromboembolism due to excessive i...
Background:Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pro...
Background. A prothrombotic state, attributable to excessive inflammation, cytokine storm, hypoxia, ...
A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early during th...
Background COVID-19 may predispose to both venous and arterial thromboembolism event (TEE). Report...
Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized COVID-19 pa...
Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized COVID-19 pa...
Introduction: Increasing evidence has declared a hypercoagulable state in the coronavirus 2019 infec...
Background: A possible association between COVID-19 infection and thrombosis, either as a direct con...
Background: There are limited data on the incidence of thrombosis among COVID-19 cases, with most re...
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pr...
Objective: An unexpectedly large number of people infected with Covid-19 had experienced a thrombo...
Item does not contain fulltextINTRODUCTION: In the first wave, thrombotic complications were common ...
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pr...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature. This article is licensed under a Cre...